Cargando…
Identification of Novel Ribonucleotide Reductase Inhibitors for Therapeutic Application in Bile Tract Cancer: An Advanced Pharmacoinformatics Study
Biliary tract cancer (BTC) is constituted by a heterogeneous group of malignant tumors that may develop in the biliary tract, and it is the second most common liver cancer. Human ribonucleotide reductase M1 (hRRM1) has already been proven to be a potential BTC target. In the current study, a de novo...
Autores principales: | Islam, Md Ataul, Barshetty, Mayuri Makarand, Srinivasan, Sridhar, Dudekula, Dawood Babu, Rallabandi, V. P. Subramanyam, Mohammed, Sameer, Natarajan, Sathishkumar, Park, Junhyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496582/ https://www.ncbi.nlm.nih.gov/pubmed/36139117 http://dx.doi.org/10.3390/biom12091279 |
Ejemplares similares
-
Screening of β1- and β2-Adrenergic Receptor Modulators through Advanced Pharmacoinformatics and Machine Learning Approaches
por: Islam, Md Ataul, et al.
Publicado: (2021) -
Identification of Potential Cytochrome P450 3A5 Inhibitors: An Extensive Virtual Screening through Molecular Docking, Negative Image-Based Screening, Machine Learning and Molecular Dynamics Simulation Studies
por: Islam, Md Ataul, et al.
Publicado: (2022) -
Classification of benign and malignant subtypes of breast cancer histopathology imaging using hybrid CNN-LSTM based transfer learning
por: Srikantamurthy, Mahati Munikoti, et al.
Publicado: (2023) -
Convergent allostery in ribonucleotide reductase
por: Thomas, William C., et al.
Publicado: (2019) -
The periodic table of ribonucleotide reductases
por: Ruskoski, Terry B., et al.
Publicado: (2021)